Marketing Researches of Market of Medications of Neuroprotective Action in Ukraine

Abstract

The assortment of neuroprotective medications, presented in the pharmaceutical market of Ukraine, has been investigated in the article. Correlation of medications of home and foreign manufacture within the limits of each pharmacotherapeutic group of medications was determined. The analysis of the assortment of neuroprotective medications has been also conducted regarding dosage forms. During research of assortment of neuroprotective action medications, present in the market of Ukraine, we used data of the State Register of Medicinal Remedies of the Ministry of Health of Ukraine. While conducting marketing analysis of the market of medications, we adhered to the АТС classification system. It was determined that home manufacturers supply the internal pharmaceutical market with 38.8% of preparations of the investigated group. Herewith, leading positions in terms of supply volume belong to ZAT (Close Joint-Stock Company), pharmaceutical firm “Darnytsia” and JSC “Galychpharm”. Preparations of each of the above-mentioned firms make 10.7% of the general assortment of home-produced medications. Rating of 25 foreign countries–suppliers of medications of neuroprotective action to the pharmaceutical market of Ukraine showed that the leader in terms of volume of the presented medications is Russia, whose medications make 16.4% of the assortment of neuroprotective medications of foreign manufacture. The second place belongs to Germany (15%), and India (11.6%) takes the third place. There was disclosed expediency of expansion of home-produced preparations nomenclature and their dosage forms for ischemic stroke treatment.

The study of development trends of the pharmaceutical market of neuroprotective drugs in Ukraine

“…The importance of the problem of acu te cerebral vascular disease, including ische mic stroke (IS), leads to a considerable inte rest of domestic and foreign scientists to search for ways of the rational pharmacotherapy of this disease, and improve pharmaceutical pro vision of patients with IS. It should be mentioned that an important role in treatment of IS belongs to neuroprotective drugs (ND), which diminish brain damage, as well as prevent the brain necrosis after an acute ischemia [4,6].…”

Phytochemical and Psychotropic Research of Motherwort (Leonurus cardiaca L.) Modified Dry Extracts

“…For the medical correction of such disorders, sedatives and anxiolytics are mainly used. When choosing sedative medicines, more than 80% of the population prefers herbal products [ 1 , 2 , 3 ].…”